Abyrx™ Announces National Distribution Partnership with SurgiCor™ to Support Growing Demand of Abyrx's Biosurgical Products in the United States' Orthopedic and Spine Marketplaces
IRVINGTON, N.Y., March 24, 2014 /PRNewswire/ -- Abyrx, Inc., a privately-held specialty biosurgical products company, today announced it has partnered with SurgiCor, LLC to significantly expand the distribution of its hemostatic bone putty products (AHBP™, Hemasorb™, Hemasorb Apply™, and Hemasorb Plus™) to orthopedic and spine surgeries throughout the United States. Under the terms of the agreement, SurgiCor will have leadership responsibility for representing Abyrx's products in a regional territory and for aggregating additional orthopedic and spine distributors throughout the United States. Abyrx and SurgiCor will use the Kairuku™ Platform to organize a variable commissioning structure for SurgiCor and its affiliate distribution representatives and to track product utilization at the point-of-care to ensure accurate and timely reporting of sales and compensation.
Founded by Jay Lawson, former President of Stryker® Corporation's spinal surgery division, and Dean Short, an orthopedic industry veteran with significant general management, sales, and supply chain experience, SurgiCor is one of the country's largest orthopedic and spine distributors with a national alliance network of over 500 product representatives who service thousands of surgical procedures each week. Abyrx will use Kairuku to seamlessly integrate SurgiCor's representatives and their affiliate partners into Abyrx's existing distribution network, which currently comprises several hundred cardiac, craniomaxillofacial, and spine representatives. Abyrx will maintain responsibility for its own product training and payment of compensation owed to SurgiCor and its partners.
Commenting on SurgiCor's partnership with Abyrx, Jay Lawson, SurgiCor's Co-Founder and Principal, stated, "SurgiCor's alignment with Abyrx and Kairuku is consistent with our mission to help companies lead their national launch of clinically relevant products to underserved markets and to work with innovative professionals who share our passion for advancing patient care. Abyrx has the most comprehensive product offering in the bone hemostasis marketplace and we believe its pipeline products have breakout potential to significantly improve patient outcomes and help reduce the cost of care."
"The current frictional dynamics that exist for new product launches to hospitals, particularly within the biosurgical products marketplace, required us to rethink the traditional distribution model and create new solutions to enable Abyrx to access and service operating rooms across surgical specialties," said John J. Pacifico, President and Chief Executive Officer of Abyrx, Inc. "Abyrx's partnership with SurgiCor and our use of the Kairuku Platform will enable us to quickly aggregate orthopedic and spine distributors throughout the United States and drive widespread adoption of Abyrx's hemostatic bone putties and pipeline products in millions of surgical procedures performed each year."
To further support the uptake of AHBP, Hemasorb, Hemasorb Apply, and Hemasorb Plus among surgeons, Abyrx's professional account liaison team members will continue to use the Kairuku Platform to recruit and partner with leading independent product representatives throughout the United States.
Founded in 2013, Abyrx develops, manufactures, and provides specialty biosurgical products for use during surgical procedures. The Company's portfolio of FDA-cleared products includes three putties that stop bone bleeding and three applicator devices. Abyrx's advanced technology platforms are being developed to create new products that have potential to support bone healing, enable approximation of bone surfaces, and deliver drugs to bone. The Company uses the Kairuku Platform to enable its product representatives to build and manage multiple point-of-care distribution channels across surgical specialties at each hospital. Abyrx's products are protected by over 40 issued and pending patents.
Abyrx is located in Irvington, New York. For more information, please visit www.abyrx.com and follow Abyrx on Twitter @abyrx.
SurgiCor is an independent agency specializing in the sale and distribution of a wide range of orthopedic devices, spinal implants, orthobiologics, and other surgical products. The founders, Jay Lawson and Dean Short, rely on decades of managerial experience in the medical device industry to provide comprehensive in-market services to emerging and established healthcare companies.
SurgiCor is located in Franklin, TN. For more information, please visit www.surgicor.com.
Founded in 2013, Kairuku is a Software-as-a-Service (SaaS) provider initially focused on helping medical product manufacturers and representatives improve the way they deliver products and services to the point-of-care at hospitals. Kairuku's solutions enable simple design of product representative compensation structures, real-time tracking of products from the point-of-shipment to the point-of-utilization, and organized delivery of information to users on mobile devices and desktop computers.
Kairuku is located in Greenwich, CT. For more information, please visit www.kairuku.com and follow Kairuku on Twitter @kairuku.
SOURCE Abyrx, Inc.